Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate the safety and efficacy of MST-188 in subjects receiving catheter-directed rt-PA for acute lower limb ischemia and to evaluate whether treatment with MST-188 results in more rapid thrombolysis of the occlusion and more rapid tissue perfusion in the effected blood vessel.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT02093468
Study type Interventional
Source Mast Therapeutics, Inc.
Contact
Status Terminated
Phase Phase 2
Start date June 2014

See also
  Status Clinical Trial Phase
Completed NCT03388021 - A Trial Comparing Routine Versus Selective Use of Completion Angiography After Surgical Thromboembolectomy in the Treatment of Acute Lower Limb Ischemia and Their Impacts on Limb Salvage Rates N/A
Recruiting NCT06222658 - The Role of Pharmaco-mechanical Thrombectomy in Management of Acute Lower Extremity Arterial Ischemia N/A
Recruiting NCT06446024 - Post Market Surveillance to Evaluate the Efficacy and Safety of the INDIGO Aspiration System in Japan
Recruiting NCT05372718 - Thrombolysis With Recombinant Non-immunogenic Staphylokinase vs Surgery in Patients With Acute Limb Ischemia FORAT Trial Phase 3
Completed NCT05138679 - Evaluation of Acute Lower Limb Ischemia
Recruiting NCT05868161 - Pounceā„¢ Thrombectomy System Retrospective Registry